TRIAD Partners

Our TRIAD partners include innovative biotech & pharmaceutical companies, award-winning researchers at top-tier universities, and those spanning the drug discovery, drug development, and diagnostics continuum for Charcot-Marie-Tooth research.

Partnerships vary depending on research goals, milestones met in preclinical or clinical development, and strategic alliance agreements.

Our most recent TRIAD partnerships & initiatives

HNF participates and supports an advocacy role by providing real-world data to the FDA and other stakeholders. Our critical data facilitates improved knowledge of the lived experience of CMT patients and the advancement of clinical development.